Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017

J Gen Intern Med. 2019 Apr;34(4):518-520. doi: 10.1007/s11606-018-4752-8.

Aishwarya Vijay¹, Joseph S Ross^{2

3

4}, Nilay D Shah^{5

6}, Molly M Jeffery^{5

6}, Sanket S Dhruva^{7

8}

¹ Yale School of Medicine, New Haven, CT, USA.
² Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA.
³ Section of General Internal Medicine, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
⁴ Department of Health Policy and Management, School of Public Health, Yale University, New Haven, CT, USA.
⁵ Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN, USA.
⁶ Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
⁷ San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA. sanket.dhruva@ucsf.edu.
⁸ Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA. sanket.dhruva@ucsf.edu.

No abstract available

Publication types